MyoKardia Inc - Company Profile

Powered by

All the sales intelligence you need on MyoKardia Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how MyoKardia Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with MyoKardia Inc.

Back to companies

MyoKardia Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on MyoKardia Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
ES2953480T3 Grant Compuestos de piperidin-urea sustituida con 4-metilsulfonilo útiles para el tratamiento de trastornos cardíacos como la cardiomiopatía dilatada (CMD) A61K31/501; A61K45/06; A61K31/506; A61P43/00; A61K31/496; A61K31/454; C07D417/12; A61K31/4545; C07D401/12; C07D401/02; C07D411/14; A61P9/00; A61P9/10; C07D401/14; C07D471/04; A61P9/04; C07D417/14; C07D407/14; C07D405/14; C07D409/02; C07D407/02; C07D413/14; C07D413/12 November 13, 2023
JP7376556B2 Grant 心臓状態に対するピリミジンジオン化合物 A61K45/06; C07D401/04; C07D413/12; A61P9/00; A61P9/12; A61K31/513; C07D405/04; C07D403/12; C07D239/545; C07D239/553; A61P9/04; C07D403/04; C07D413/04; A61P9/10; C07D401/12; C07D405/12 November 08, 2023
WO2023211872A1 Application Methods of administering myosin inhibitors A61K31/513; A61P9/00; A61P9/04; G16H20/10 November 02, 2023
CA2974370C Grant 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (DCM) C07D401/02; C07D411/14; C07D405/14; C07D407/02; C07D413/14; C07D409/02; A61P9/10; C07D401/12; A61P9/04; C07D407/14; C07D417/14; C07D417/12; C07D401/14; A61P9/00; A61K31/454; C07D413/12; A61P43/00; A61K31/4545; A61K31/501; A61K45/06; A61K31/506; C07D471/04; A61K31/496 October 31, 2023
SI3247707T1 Grant 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (DCM) A61P9/10; C07D405/14; C07D409/02; A61P9/00; A61K45/06; A61K31/4545; A61K31/501; A61P43/00; A61P9/04; C07D413/12; C07D407/02; C07D413/14; C07D407/14; A61K31/506; C07D401/02; C07D411/14; C07D417/14; A61K31/454; C07D401/12; C07D401/14; C07D417/12; A61K31/496; C07D471/04 October 30, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer